FMA Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Buy
+200
New +$204K 0.15% 36
2026
Q1
Sell
-200
Closed -$215K 44
2025
Q4
$215K Buy
+200
New +$191K 0.14% 44
2025
Q2
Sell
-300
Closed -$276K 45
2025
Q1
$276K Hold
300
0.21% 34
2024
Q4
$232K Sell
300
-50
-14% -$41.4K 0.17% 37
2024
Q3
$310K Sell
350
-15
-4% -$13.5K 0.22% 32
2024
Q2
$330K Sell
365
-100
-22% -$80K 0.27% 34
2024
Q1
$362K Hold
465
0.3% 33
2023
Q4
$271K Buy
+465
New +$271K 0.25% 35

Other funds holding LLY

FMA Wealth Management's LLY Position: Q2 2026 in Review

FMA Wealth Management opened a new position in Eli Lilly (LLY) in Q2 2026: 200 shares worth $240K. The stake represents 0.15% of the portfolio and ranks #36 among its holdings. This is a return to the name: FMA Wealth Management previously reported a position in LLY as recently as Q4 2025.

FMA Wealth Management first reported a position in LLY in Q4 2023 and has held it in 8 quarters since. The position peaked at $362K in Q1 2024. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • FMA Wealth Management held 200 shares of Eli Lilly worth $240K as of Q2 2026.
  • Eli Lilly was a new FMA Wealth Management position in Q2 2026.
  • Eli Lilly made up 0.15% of FMA Wealth Management's portfolio in Q2 2026, its #36 holding.
  • FMA Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 8 quarters since.
  • FMA Wealth Management's Eli Lilly position peaked at $362K in Q1 2024.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FMA Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.